RE: Mutation, vaccine, antigen and PCR20 Dec 2020 17:06
Lets hope it does nt take the salesmen that long , i am hoping for sales early next year or else why did Beckman give GDR a kick up the backside , they also want to get things moving . They have no control on approvals but as i read the rns Beckman seemed to be getting a little impatient as they are ready to go hence the reason for the rns this week. I was hoping for a little momentum from the rise this week but it seems there is no love for gdr from the market as there is with other covid companies so the only thing that will move the sp significantly is signed sales contracts, but the beauty with gdr that with a low number of shares in issue we are not going to need the sales nyct have to re rate the sp to a lot higher level than we are atm.